{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:01:51Z","timestamp":1793638911992,"version":"4.5.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CIBER-Consorcio Centro de Investigaci\u00f3n Biom\u00e9dica en Red","award":["CB21\/13\/00120"],"award-info":[{"award-number":["CB21\/13\/00120"]}]},{"name":"Instituto de Salud Carlos III, Ministerio de Ciencia, Innovaci\u00f3n y Universidades and by the Spanish Strategic Health Action","award":["P121CIII\/00034"],"award-info":[{"award-number":["P121CIII\/00034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Nigeria accounts for the greatest burden of malaria disease globally. Malaria control requires an effective treatment after diagnosis. The efficacy of antimalarial drugs can be assessed through the analysis of genetic changes associated with reduced drug sensitivity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study includes the analysis of the markers associated with artemisinin (<jats:italic>pfk13<\/jats:italic>), sulfadoxine\u2013pyrimethamine (<jats:italic>pfdhfr<\/jats:italic> and <jats:italic>pfdhps<\/jats:italic>), and chloroquine and its derivatives (<jats:italic>pfmdr1<\/jats:italic> and <jats:italic>pfcrt<\/jats:italic>) resistances, in blood samples collected from asymptomatic children in south-western Nigeria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The 25.95% of samples showed a number of mutations in <jats:italic>pfk13<\/jats:italic> gene. Among those, the validated, C580Y, and the candidate, R515K, mutations by WHO were detected. Twenty-seven <jats:italic>pfdhps<\/jats:italic> different haplotypes were observed, with the haplotype IS<jats:bold>G<\/jats:bold>KAA as the most prevalent (18.80%), followed by I<jats:bold>FG<\/jats:bold>KAA (12.78%) and I<jats:bold>AG<\/jats:bold>KAA (11.28%). The <jats:bold>VAG<\/jats:bold>K<jats:bold>GS<\/jats:bold> was the most common haplotype carrying the I431V mutation (10.53%). Combinations of alleles in <jats:italic>pfdhfr<\/jats:italic> and <jats:italic>pfdhps<\/jats:italic> genes provided a 40.98% of samples with the partially resistant haplotype (<jats:bold>IRNG<\/jats:bold>). No samples exhibited the \u2018fully resistant\u2019 or \u2018super resistant\u2019 <jats:italic>pfdhprf<\/jats:italic>\u2013<jats:italic>pfdhps<\/jats:italic> combinations, but one sample contained mutations at <jats:italic>pfdhfr<\/jats:italic> 51I, 59R, and 108N with <jats:italic>pfdhps<\/jats:italic> 431V, 436A, A437G and 540E. The analysis of <jats:italic>pfcrt<\/jats:italic> 72\u201376 variants disclosed a 12.12% of samples with the mutant-type (CV<jats:bold>IET<\/jats:bold>). No double mutant <jats:italic>pfmdr1<\/jats:italic> haplotypes 86Y\/1246Y (YY) were detected, nor was the haplotype formed by the alleles 86Y <jats:italic>pfmdr1<\/jats:italic>\u2009+\u2009<jats:italic>pfcrt<\/jats:italic> 76\u00a0T (YT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>There was no evidence of parasite genomes harbouring multilocus mutations conferring multidrug resistance, although evidence of a validated (C580Y) and a candidate (R515K) mutation in <jats:italic>pfk13<\/jats:italic> gene, high frequency <jats:italic>pfdhfr<\/jats:italic> mutant alleles and high variability of <jats:italic>pfdhps<\/jats:italic> haplotypes were found in this study, which provides a baseline information essential in monitoring <jats:italic>P. falciparum<\/jats:italic> resistances.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41182-025-00732-6","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:16:19Z","timestamp":1744096579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mutational profile of pfdhfr, pfdhps, pfmdr1, pfcrt and pfk13 genes of P. falciparum associated with resistance to different antimalarial drugs in Osun state, southwestern Nigeria"],"prefix":"10.1186","volume":"53","author":[{"given":"Alexandra","family":"Mart\u00edn Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akeem Abiodun","family":"Akindele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicenta","family":"Gonz\u00e1lez Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"de la Torre-Capit\u00e1n Mat\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Molina de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman Adebayo","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy-Huong","family":"Ta-Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Berzosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"732_CR1","unstructured":"World malaria report 2024: addressing inequity in the global malaria response. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"732_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40249-020-00712-4","volume":"9","author":"H Quan","year":"2020","unstructured":"Quan H, Igbasi U, Oyibo W, Omilabu S, Chen SB, Shen HM, et al. High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria. Infect Dis Poverty. 2020;9(1):91.","journal-title":"Infect Dis Poverty"},{"key":"732_CR3","unstructured":"WHO guidelines for malaria, 16 October 2023. Geneva: World Health Organization; 2023 (WHO\/UCN\/GMP\/ 2023.01 Rev.1). License: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"732_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3201\/eid2401.170864","volume":"24","author":"H Gupta","year":"2017","unstructured":"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, et al. Drug-resistant polymorphisms and copy numbers in plasmodium falciparum, mozambique, 2015. Emerg Infect Dis. 2017;24(1):40\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"732_CR5","doi-asserted-by":"publisher","first-page":"e00019","DOI":"10.1128\/CMR.00019-19","volume":"32","author":"XZ Su","year":"2019","unstructured":"Su XZ, Lane KD, Xia L, S\u00e1 JM, Wellems TE. Plasmodium genomics and genetics: new insights into malaria pathogenesis, drug resistance, epidemiology, and evolution. Clin Microbiol Rev. 2019;32(4):e00019-19.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"732_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum Malaria. N Engl J Med. 2014;371(5):411\u201323.","journal-title":"N Engl J Med"},{"issue":"10","key":"732_CR7","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana JLM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26(10):1602\u20138.","journal-title":"Nat Med"},{"key":"732_CR8","unstructured":"World malaria report 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"732_CR9","unstructured":"World malaria report 2023. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"25","key":"732_CR10","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1056\/NEJMe1604520","volume":"374","author":"JP Daily","year":"2016","unstructured":"Daily JP. K13-propeller mutations and malaria resistance. N Engl J Med. 2016;374(25):2492\u20133.","journal-title":"N Engl J Med"},{"issue":"25","key":"732_CR11","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374(25):2453\u201364.","journal-title":"N Engl J Med"},{"key":"732_CR12","unstructured":"WHO. Malaria: Artemisinin partial resistance [Internet]. [cited 2024 Jul 10]. Available from: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/artemisinin-resistance"},{"issue":"7","key":"732_CR13","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/infdis\/jiz247","volume":"220","author":"K O\u2019Flaherty","year":"2019","unstructured":"O\u2019Flaherty K, Ata\u00edde R, Zaloumis SG, Ashley EA, Powell R, Feng G, et al. Contribution of functional antimalarial immunity to measures of parasite clearance in therapeutic efficacy studies of artemisinin derivatives. J Infect Dis. 2019;220(7):1178\u201387.","journal-title":"J Infect Dis"},{"issue":"1","key":"732_CR14","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1038\/s41467-022-33873-x","volume":"13","author":"PK Tumwebaze","year":"2022","unstructured":"Tumwebaze PK, Conrad MD, Okitwi M, Orena S, Byaruhanga O, Katairo T, et al. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun. 2022;13(1):6353.","journal-title":"Nat Commun"},{"issue":"4","key":"732_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4269\/ajtmh.23-0740","volume":"110","author":"W Van Loon","year":"2024","unstructured":"Van Loon W, Bisimwa BC, Byela V, Kirby R, Bugeme PM, Balagizi A, et al. Detection of artemisinin resistance marker kelch-13 469Y in Plasmodium falciparum, South Kivu, democratic republic of the Congo, 2022. Am J Trop Med Hyg. 2024;110(4):653\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"732_CR16","unstructured":"Directrices de la OMS sobre la malaria [Internet]. [cited 2024 Sep 5]. Available from: https:\/\/www.who.int\/es\/publications\/i\/item\/guidelines-for-malaria"},{"issue":"1","key":"732_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12936-022-04115-8","volume":"21","author":"CV Plowe","year":"2022","unstructured":"Plowe CV. Malaria chemoprevention and drug resistance: a review of the literature and policy implications. Malar J. 2022;21(1):104.","journal-title":"Malar J"},{"issue":"9","key":"732_CR18","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1093\/jac\/dkv160","volume":"70","author":"P Chauvin","year":"2015","unstructured":"Chauvin P, Menard S, Iriart X, Nsango SE, Tchioffo MT, Abate L, et al. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine\/pyrimethamine in pregnant women in Yaound\u00e9, Cameroon: emergence of highly resistant pfdhfr\/pfdhps alleles. J Antimicrob Chemother. 2015;70(9):2566\u201371.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"732_CR19","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1086\/588144","volume":"197","author":"A Mayor","year":"2008","unstructured":"Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, et al. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants. J Infect Dis. 2008;197(12):1737\u201342.","journal-title":"J Infect Dis"},{"key":"732_CR20","doi-asserted-by":"crossref","unstructured":"Berzosa P, Molina De La Fuente I, Ta-Tang TH, Gonz\u00e1lez V, Garc\u00eda L, Rodr\u00edguez-Galet A, et al. Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20 years (1999 to 2019). Malar J. 2021;20(1):463.","DOI":"10.1186\/s12936-021-04000-w"},{"issue":"3","key":"732_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00436-018-5754-5","volume":"117","author":"E Esu","year":"2018","unstructured":"Esu E, Tacoli C, Gai P, Berens-Riha N, Pritsch M, Loescher T, et al. Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria. Parasitol Res. 2018;117(3):801\u20137.","journal-title":"Parasitol Res"},{"issue":"11","key":"732_CR22","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/tropicalmed8110504","volume":"8","author":"H Quan","year":"2023","unstructured":"Quan H, Yu P, Kassegne K, Shen HM, Chen SB, Chen JH. Polymorphism of drug resistance genes dhfr and dhps in Plasmodium falciparum Isolates among Chinese migrant workers who returned from Ghana in 2013. Trop Med Infect Dis. 2023;8(11):504.","journal-title":"Trop Med Infect Dis"},{"issue":"12","key":"732_CR23","doi-asserted-by":"publisher","first-page":"e983","DOI":"10.1016\/S2666-5247(23)00211-2","volume":"4","author":"E Gu\u00e9mas","year":"2023","unstructured":"Gu\u00e9mas E, Copp\u00e9e R, M\u00e9nard S, Du Manoir M, Nsango S, Makaba Mvumbi D, et al. Evolution and spread of Plasmodium falciparum mutations associated with resistance to sulfadoxine\u2013pyrimethamine in central Africa: a cross-sectional study. Lancet Microbe. 2023;4(12):e983\u201393.","journal-title":"Lancet Microbe"},{"issue":"8","key":"732_CR24","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1128\/AAC.00024-09","volume":"53","author":"CJ Sutherland","year":"2009","unstructured":"Sutherland CJ, Fifer H, Pearce RJ, Bin Reza F, Nicholas M, Haustein T, et al. Novel pfdhps Haplotypes among Imported Cases of Plasmodium falciparum Malaria in the United Kingdom. Antimicrob Agents Chemother. 2009;53(8):3405\u201310.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"732_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","volume":"29","author":"I Naidoo","year":"2013","unstructured":"Naidoo I, Roper C. Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria. Trends Parasitol. 2013;29(10):505\u201315.","journal-title":"Trends Parasitol"},{"key":"732_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/950424","volume":"2014","author":"ZO Ibraheem","year":"2014","unstructured":"Ibraheem ZO, Abd Majid R, Noor SM, Sedik HM, Basir R. Role of different Pf crt and Pf mdr-1 mutations in conferring resistance to antimalaria drugs in Plasmodium falciparum. Malar Res Treat. 2014;2014:1\u201317.","journal-title":"Malar Res Treat."},{"issue":"10","key":"732_CR27","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1086\/320195","volume":"183","author":"HA Babiker","year":"2001","unstructured":"Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D. High-level chloroquine resistance in sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the Multidrug Resistance Gene pfmdr1. J Infect Dis. 2001;183(10):1535\u20138.","journal-title":"J Infect Dis"},{"key":"732_CR28","doi-asserted-by":"crossref","unstructured":"Shrivastava SK, Gupta RK, Mahanta J, Dubey ML. Correlation of Molecular Markers, Pfmdr1-N86Y and Pfcrt-K76T, with In Vitro Chloroquine Resistant Plasmodium falciparum, Isolated in the Malaria Endemic States of Assam and Arunachal Pradesh, Northeast India. Smith TA, editor. PLoS ONE. 2014;9(8):e103848.","DOI":"10.1371\/journal.pone.0103848"},{"key":"732_CR29","doi-asserted-by":"publisher","first-page":"1167220","DOI":"10.3389\/fcimb.2023.1167220","volume":"13","author":"S Wang","year":"2023","unstructured":"Wang S, Huang F, Yan H, Yin J, Xia Z. A review of malaria molecular markers for drug resistance in Plasmodium falciparum and Plasmodium vivax in China. Front Cell Infect Microbiol. 2023;13:1167220.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"732_CR30","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","volume":"9","author":"LS Ross","year":"2018","unstructured":"Ross LS, Dhingra SK, Mok S, Yeo T, Wicht KJ, K\u00fcmpornsin K, et al. Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nat Commun. 2018;9(1):3314.","journal-title":"Nat Commun"},{"issue":"1","key":"732_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4269\/ajtmh.2006.75.155","volume":"75","author":"CT Happi","year":"2006","unstructured":"Happi CT, Gbotosho GO, Folarin OA, Bolaji OM, Sowunmi A, Kyle DE, et al. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. Am J Trop Med Hyg. 2006;75(1):155\u201361.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"732_CR32","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gn\u00e4dig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7(1):11553.","journal-title":"Nat Commun"},{"issue":"3","key":"732_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(22)00593-X","volume":"23","author":"KB Beshir","year":"2023","unstructured":"Beshir KB, Muwanguzi J, Nader J, Mansukhani R, Traore A, Gamougam K, et al. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine\u2013pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study. Lancet Infect Dis. 2023;23(3):361\u201370.","journal-title":"Lancet Infect Dis"},{"issue":"9432","key":"732_CR34","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. The Lancet. 2004;364(9432):438\u201347.","journal-title":"The Lancet"},{"key":"732_CR35","unstructured":"Federal ministry of health, Abuja, Nigeria. National malaria strategic plan 2021\u20132025. 2020."},{"issue":"1","key":"732_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12936-019-2833-8","volume":"18","author":"TM Dokunmu","year":"2019","unstructured":"Dokunmu TM, Adjekukor CU, Yakubu OF, Bello AO, Adekoya JO, Akinola O, et al. Asymptomatic malaria infections and Pfmdr1 mutations in an endemic area of Nigeria. Malar J. 2019;18(1):218.","journal-title":"Malar J"},{"key":"732_CR37","doi-asserted-by":"crossref","unstructured":"Dokunmu TM, Olasehinde GI, Oladejo DO, Olanrewaju O, Akinbobola A, Adjekukor CU, et al. Efficiency of histidine rich protein II-based rapid diagnostic tests for monitoring malaria transmission intensities in an endemic area. In Ho Chi Minh City, Vietnam; 2018 [cited 2024 Jul 10]. p. 030001. Available from: https:\/\/pubs.aip.org\/aip\/acp\/article\/753586","DOI":"10.1063\/1.5033381"},{"key":"732_CR38","unstructured":"Federal Republic of Nigeria. National Antimalarial Treatment Policy, Federal Ministry of Health National Malaria and Vector Control Division, Abuja-Nigeria. 2005."},{"issue":"Suppl 1","key":"732_CR39","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1016\/S0035-9203(02)90077-5","volume":"96","author":"JM Rubio","year":"2002","unstructured":"Rubio JM, Post RJ, van Leeuwen WMD, Henry MC, Lindergard G, Hommel M. Alternative polymerase chain reaction method to identify Plasmodium species in human blood samples: the semi-nested multiplex malaria PCR (SnM-PCR). Trans R Soc Trop Med Hyg. 2002;96(Suppl 1):S199-204.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"732_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.apjtm.2017.03.014","volume":"10","author":"M Miguel-Oteo","year":"2017","unstructured":"Miguel-Oteo M, Jiram AI, Ta-Tang TH, Lanza M, Hisam S, Rubio JM. Nested multiplex PCR for identification and detection of human Plasmodium species including Plasmodium knowlesi. Asian Pac J Trop Med. 2017;10(3):299\u2013304.","journal-title":"Asian Pac J Trop Med"},{"issue":"6","key":"732_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","volume":"52","author":"CV Plowe","year":"1995","unstructured":"Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52(6):565\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"732_CR42","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760210210","volume":"116","author":"TH Ta-Tang","year":"2021","unstructured":"Ta-Tang TH, Berzosa P, Rubio JM, Romay-Barja M, Ncogo P, Agudo D, et al. Evaluation of LAMP for the diagnosis of Loa loa infection in dried blood spots compared to PCR-based assays and microscopy. Mem Inst Oswaldo Cruz. 2021;116: e210210.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"7481","key":"732_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505(7481):50\u20135.","journal-title":"Nature"},{"key":"732_CR44","doi-asserted-by":"crossref","unstructured":"Didier M, Menard D, Ariey F. PCR_Sequencing for genotyping SNPs PF3D7_1343700 Kelch protein propeller domain. Protoc Exch [Internet]. 2013 Dec 19 [cited 2024 Jul 10]; Available from: https:\/\/www.nature.com\/protocolexchange\/protocols\/2927","DOI":"10.1038\/protex.2013.096"},{"issue":"3","key":"732_CR45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403\u201310.","journal-title":"J Mol Biol"},{"issue":"1","key":"732_CR46","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12936-021-03968-9","volume":"20","author":"M Ikegbunam","year":"2021","unstructured":"Ikegbunam M, Ojo JA, Kokou K, Morikwe U, Nworu C, Uba C, et al. Absence of Plasmodium falciparum artemisinin resistance gene mutations eleven years after the adoption of artemisinin-based combination therapy in Nigeria. Malar J. 2021;20(1):434.","journal-title":"Malar J"},{"issue":"6","key":"732_CR47","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ijantimicag.2017.01.032","volume":"49","author":"M Madamet","year":"2017","unstructured":"Madamet M, Kounta MB, Wade KA, Lo G, Diawara S, Fall M, et al. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal. Int J Antimicrob Agents. 2017;49(6):754\u20136.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"732_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264548","volume":"17","author":"FV Ajogbasile","year":"2022","unstructured":"Ajogbasile FV, Oluniyi PE, Kayode AT, Akano KO, Adegboyega BB, Philip C, et al. Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria. PLoS ONE. 2022;17(2): e0264548.","journal-title":"PLoS ONE"},{"issue":"8","key":"732_CR49","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/tmi.13273","volume":"24","author":"U Igbasi","year":"2019","unstructured":"Igbasi U, Oyibo W, Omilabu S, Quan H, Chen S, Shen H, et al. Kelch 13 propeller gene polymorphism among Plasmodium falciparum isolates in Lagos, Nigeria: molecular Epidemiologic Study. Trop Med Int Health. 2019;24(8):1011\u20137.","journal-title":"Trop Med Int Health"},{"issue":"5","key":"732_CR50","doi-asserted-by":"publisher","first-page":"e00528","DOI":"10.1128\/spectrum.00528-22","volume":"10","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang X, Chen H, Zhang J, Lu Q, Ruan W, et al. Molecular epidemiology of drug resistance genes in Plasmodium falciparum isolates imported from Nigeria between 2016 and 2020: continued emergence of fully resistant Pfdhfr-Pfdhps Alleles. Microbiol Spectr. 2022;10(5):e00528-e622.","journal-title":"Microbiol Spectr."},{"issue":"10","key":"732_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240174","volume":"15","author":"H Gupta","year":"2020","unstructured":"Gupta H, Galatas B, Chidimatembue A, Huijben S, Cister\u00f3 P, Matambisso G, et al. Effect of mass dihydroartemisinin\u2013piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance. PLoS ONE. 2020;15(10): e0240174.","journal-title":"PLoS ONE"},{"issue":"1","key":"732_CR52","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12936-018-2506-z","volume":"17","author":"G Mart\u00ednez-P\u00e9rez","year":"2018","unstructured":"Mart\u00ednez-P\u00e9rez G, Lansana DP, Omeonga S, Gupta H, Breeze-Barry B, Gonz\u00e1lez R, et al. Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, Liberia. Malar J. 2018;17(1):357.","journal-title":"Malar J"},{"issue":"1","key":"732_CR53","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s13104-020-05334-5","volume":"13","author":"M Tola","year":"2020","unstructured":"Tola M, Ajibola O, Idowu ET, Omidiji O, Awolola ST, Amambua-Ngwa A. Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria. BMC Res Notes. 2020;13(1):497.","journal-title":"BMC Res Notes"},{"issue":"7549","key":"732_CR54","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","volume":"520","author":"A Mbengue","year":"2015","unstructured":"Mbengue A, Bhattacharjee S, Pandharkar T, Liu H, Estiu G, Stahelin RV, et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature. 2015;520(7549):683\u20137.","journal-title":"Nature"},{"key":"732_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2023.105460","volume":"112","author":"WA Azmi","year":"2023","unstructured":"Azmi WA, Rizki AFM, Djuardi Y, Artika IM, Siregar JE. Molecular insights into artemisinin resistance in Plasmodium falciparum: an updated review. Infect Genet Evol. 2023;112: 105460.","journal-title":"Infect Genet Evol"},{"issue":"5","key":"732_CR56","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/infdis\/jiu467","volume":"211","author":"SM Taylor","year":"2015","unstructured":"Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2015;211(5):680\u20138.","journal-title":"J Infect Dis"},{"key":"732_CR57","doi-asserted-by":"crossref","unstructured":"Molina-de La Fuente I, Sagrado Benito MJ, Ousley J, Gisbert FDB, Garc\u00eda L, Gonz\u00e1lez V, et al. Screening for K13-Propeller Mutations Associated with Artemisinin Resistance in Plasmodium falciparum in Yambio County (Western Equatoria State, South Sudan). Am J Trop Med Hyg. 2023;109(5):1072\u20136.","DOI":"10.4269\/ajtmh.23-0382"},{"key":"732_CR58","unstructured":"WHO | Regional Office for Africa [Internet]. 2024 [cited 2024 Sep 5]. Recommendations on the use of Sulfadoxine Pyrimethamine (SP) for Intermittent Preventive Treatment during Pregnancy (IPT) in areas of moderate to high resistance to SP in the African Region. Available from: https:\/\/www.afro.who.int\/publications\/recommendations-use-sulfadoxine-pyrimethamine-sp."},{"key":"732_CR59","unstructured":"Updated WHO recommendations for malaria chemoprevention among children and pregnant women [Internet]. [cited 2024 Sep 5]. Available from: https:\/\/www.who.int\/news\/item\/03-06-2022-Updated-WHO-recommendations-for-malaria-chemoprevention-among-children-and-pregnant-women."},{"key":"732_CR60","unstructured":"National Malaria Estrategic Plan 2021-2025. [Internet]. [cited 2024 Sep 5]. Available from: http:\/\/nmcp.gov.ng\/."},{"key":"732_CR61","doi-asserted-by":"crossref","unstructured":"Travassos MA, Laufer MK. Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations. Pediatr Res. 2009;65(5 Part 2):64R\u201370R.","DOI":"10.1203\/PDR.0b013e3181a0977e"},{"key":"732_CR62","doi-asserted-by":"publisher","first-page":"jiz451","DOI":"10.1093\/infdis\/jiz451","volume":"221","author":"S Huijben","year":"2019","unstructured":"Huijben S, Macete E, Mombo-Ngoma G, Ramharter M, Kariuki S, Desai M, et al. Counter-selection of antimalarial resistance polymorphisms by intermittent preventive treatment in pregnancy. J Infect Dis. 2019;221:jiz451.","journal-title":"J Infect Dis"},{"issue":"1","key":"732_CR63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12936-023-04487-5","volume":"22","author":"AJ Adegbola","year":"2023","unstructured":"Adegbola AJ, Ijarotimi OA, Ubom AE, Adesoji BA, Babalola OE, Hocke EF, et al. A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria. Malar J. 2023;22(1):71.","journal-title":"Malar J"},{"issue":"5","key":"732_CR64","doi-asserted-by":"publisher","first-page":"e02005","DOI":"10.1128\/spectrum.02005-22","volume":"10","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang X, Chen H, Lu Q, Ruan W, Chen Z. Molecular determinants of sulfadoxine-pyrimethamine resistance in plasmodium falciparum isolates from central Africa between 2016 and 2021: wide geographic spread of highly mutated Pfdhfr and Pfdhps alleles. Microbiol Spectr. 2022;10(5):e02005-e2022.","journal-title":"Microbiol Spectr."},{"issue":"1","key":"732_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12936-021-03713-2","volume":"20","author":"ER Ebel","year":"2021","unstructured":"Ebel ER, Reis F, Petrov DA, Beleza S. Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola. Malar J. 2021;20(1):175.","journal-title":"Malar J"},{"key":"732_CR66","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa062032","volume":"355","author":"R Waring","year":"2006","unstructured":"Waring R. Return of chloroquine antimalarial efficacy in malawi. N Engl J Med. 2006;355:1959\u201366.","journal-title":"N Engl J Med"},{"key":"732_CR67","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.meegid.2018.10.007","volume":"66","author":"MA Oboh","year":"2018","unstructured":"Oboh MA, Singh US, Antony HA, Ndiaye D, Badiane AS, Ali NA, et al. Molecular epidemiology and evolution of drug-resistant genes in the malaria parasite Plasmodium falciparum in southwestern Nigeria. Infect Genet Evol. 2018;66:222\u20138.","journal-title":"Infect Genet Evol"},{"issue":"4","key":"732_CR68","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijpara.2020.10.001","volume":"51","author":"AT Kayode","year":"2021","unstructured":"Kayode AT, Akano K, Ajogbasile FV, Uwanibe JN, Oluniyi PE, Bankole BE, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and multidrug-resistant gene 1 (Pfmdr-1) in Nigerian children 10 years post-adoption of artemisinin-based combination treatments. Int J Parasitol. 2021;51(4):301\u201310.","journal-title":"Int J Parasitol"},{"key":"732_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.105042","volume":"95","author":"CO Agomo","year":"2021","unstructured":"Agomo CO, Mishra N, Olukosi YA, Gupta R, Kamlesh K, Aina OO, et al. Mutations in Pfcrt and Pfmdr1 genes of Plasmodium falciparum isolates from two sites in Northcentral and Southwest Nigeria. Infect Genet Evol. 2021;95: 105042.","journal-title":"Infect Genet Evol"},{"issue":"1","key":"732_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/diseases9010006","volume":"9","author":"R Adam","year":"2021","unstructured":"Adam R, Mukhtar MM, Abubakar UF, Damudi HA, Muhammad A, Ibrahim SS. Polymorphism analysis of pfmdr1 and pfcrt from Plasmodium falciparum Isolates in Northwestern Nigeria revealed the major markers associated with antimalarial resistance. Diseases. 2021;9(1):6.","journal-title":"Diseases"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00732-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:01:17Z","timestamp":1744218077000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00732-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00732-6","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the research was obtained from the Research and Ethics Committee of Osun State, Ministry of Health, Osogbo, Nigeria (reference number: OSHREC\/PRS\/569\u00a0T\/131) and performed in accordance with relevant guidelines and regulations. Informed consent was obtained from all children parents\/caregivers upon enrolment. Permission was sought from the local inspector of education, head teacher and community leaders.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}